{
  "company": {
    "name": "Creyon Bio",
    "website": "https://creyonbio.com/",
    "record": "https://startuphistory.org/c/creyonbio.com"
  },
  "status": null,
  "history_since": "2022-03-08T12:32:35.000Z",
  "baseline": {
    "snapshot_id": "c0f258b75aca70be0a3b066d4bc7b14c91cb0224ac18601173715e7df4742627",
    "observed_at": "2022-03-08T12:32:35.000Z",
    "headline": null,
    "description": "Creyon Bio is reinventing drug development from the ground up and making on-demand oligonucleotide therapeutics possible.",
    "evidence": "https://web.archive.org/web/20220308123235/https://creyonbio.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T13:05:45.745Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2025-10-10T16:02:55.000Z",
      "variants": [
        {
          "headline": "Reimagining drug development as it should be.",
          "subhead": "Creyon Bio is reinventing drug development from the ground up and making on-demand oligonucleotide therapeutics possible.",
          "observed_at": "2023-02-01T09:55:59.000Z",
          "evidence": "https://web.archive.org/web/20230201095559/https://creyonbio.com",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reimagining drug development as it should be.",
          "subhead": "Creyon Bio is reinventing drug development from the ground up and making on-demand oligonucleotide therapeutics possible.",
          "observed_at": "2023-09-09T06:53:46.000Z",
          "evidence": "https://web.archive.org/web/20230909065346/https://creyonbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reimagining drug development as it should be.",
          "subhead": "Creyon Bio is reinventing drug development from the ground up and making on-demand oligonucleotide therapeutics possible.",
          "observed_at": "2024-01-04T08:18:48.000Z",
          "evidence": "https://web.archive.org/web/20240104081848/https://creyonbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reimagining drug development as it should be.",
          "subhead": "Creyon Bio is reinventing drug development from the ground up and making on-demand oligonucleotide therapeutics possible.",
          "observed_at": "2024-07-25T06:08:56.000Z",
          "evidence": "https://web.archive.org/web/20240725060856/https://creyonbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reimagining drug development as it should be.",
          "subhead": "Creyon Bio is reinventing drug development from the ground up and making on-demand oligonucleotide therapeutics possible.",
          "observed_at": "2025-01-22T15:15:02.000Z",
          "evidence": "https://web.archive.org/web/20250122151502/https://creyonbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reimagining drug development as it should be.",
          "subhead": "Creyon Bio is reinventing drug development from the ground up and making on-demand oligonucleotide therapeutics possible.",
          "observed_at": "2025-07-09T22:30:28.000Z",
          "evidence": "https://web.archive.org/web/20250709223028/https://creyonbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reimagining drug development as it should be.",
          "subhead": "Creyon Bio is reinventing drug development from the ground up and making on-demand oligonucleotide therapeutics possible.",
          "observed_at": "2025-08-02T17:26:43.000Z",
          "evidence": "https://web.archive.org/web/20250802172643/https://creyonbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reimagining drug development as it should be.",
          "subhead": "Creyon Bio is reinventing drug development from the ground up and making on-demand oligonucleotide therapeutics possible.",
          "observed_at": "2025-10-10T16:02:55.000Z",
          "evidence": "https://web.archive.org/web/20251010160255/https://creyonbio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Reimagining drug development as it should be.",
      "subhead": "Creyon Bio is reinventing drug development from the ground up and making on-demand oligonucleotide therapeutics possible.",
      "from": "2023-02-01T09:55:59.000Z",
      "to": "2025-10-10T16:02:55.000Z",
      "captures": 8,
      "evidence": "https://web.archive.org/web/20251010160255/https://creyonbio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2023-02-01T09:55:59.000Z",
          "to": "2025-10-10T16:02:55.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-05T13:05:45.745Z",
      "variants": [
        {
          "headline": "Transforming RNA Drug Design with Targeted Delivery and AI-Driven Precision",
          "subhead": "Creyon is a drug development company enabling tissue specific delivery of RNA therapies designed to improve safety, efficacy, and patient experience in immunology, central nervous system (CNS), and ne",
          "observed_at": "2026-11-05T13:05:45.745Z",
          "evidence": "https://creyon.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Transforming RNA Drug Design with Targeted Delivery and AI-Driven Precision",
      "subhead": "Creyon is a drug development company enabling tissue specific delivery of RNA therapies designed to improve safety, efficacy, and patient experience in immunology, central nervous system (CNS), and ne",
      "from": "2026-11-05T13:05:45.745Z",
      "to": "2026-11-05T13:05:45.745Z",
      "captures": 1,
      "evidence": "https://creyon.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-05T13:05:45.745Z"
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-f6ccc0dd6991ff0c2f43b05350c1afb592f07b3a14f0b8f9f0ddd05485b06cea:1d8368f3105ec4a3d85f531d7c78f6e64422016adc3a433c3308402baa910c28:headline:378eb01d711f6f81",
      "before_evidence": "https://web.archive.org/web/20251010160255/https://creyonbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Reimagining drug development as it should be.” to “Transforming RNA Drug Design with Targeted Delivery and AI-Driven Precision”.",
      "between": {
        "from": "2025-10-10T16:02:55.000Z",
        "to": "2026-11-05T13:05:45.745Z"
      },
      "evidence": "https://creyon.com/",
      "evidence_kind": "live_capture",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Creyon Bio” company record, https://startuphistory.org/c/creyonbio.com"
}